The effect of isradipine, a new calcium-channel antagonist, in patients with primary Raynaud's phenomenon: a single-blind dose-response study.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/F1CEFD72.svg?ark=w1%2F20260515%2FF1CEFD72)](https://nobleid.org/work/w1/20260515/F1CEFD72)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors